Radiopharmaceutical therapy in cancer: Clinical advances and challenges Review
| Authors: | Sgouros, G.; Bodei, L.; McDevitt, M. R.; Nedrow, J. R. |
| Review Title: | Radiopharmaceutical therapy in cancer: Clinical advances and challenges |
| Abstract: | Radiopharmaceutical therapy (RPT) is emerging as a safe and effective targeted approach to treating many types of cancer. In RPT, radiation is systemically or locally delivered using pharmaceuticals that either bind preferentially to cancer cells or accumulate by physiological mechanisms. Almost all radionuclides used in RPT emit photons that can be imaged, enabling non-invasive visualization of the biodistribution of the therapeutic agent. Compared with almost all other systemic cancer treatment options, RPT has shown efficacy with minimal toxicity. With the recent FDA approval of several RPT agents, the remarkable potential of this treatment is now being recognized. This Review covers the fundamental properties, clinical development and associated challenges of RPT. © 2020, Springer Nature Limited. |
| Journal Title: | Nature Reviews Drug Discovery |
| Volume: | 19 |
| Issue: | 9 |
| ISSN: | 1474-1776 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2020-09-01 |
| Start Page: | 589 |
| End Page: | 608 |
| Language: | English |
| DOI: | 10.1038/s41573-020-0073-9 |
| PUBMED: | 32728208 |
| PROVIDER: | scopus |
| PMCID: | PMC7390460 |
| DOI/URL: | |
| Notes: | Correction issued, see Doi: 10.1038/s41573-020-0085-5 -- Review -- Export Date: 1 October 2020 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work